DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 5Dr. Reddy's Laboratories
02 1Supriya Lifescience
03 2Accord Healthcare Pty. Ltd.
04 15Accord healthcare
05 4Accure Labs
06 3Actavis Inc
07 1Almaject
08 2Amneal Pharmaceuticals
09 3Aurobindo Pharma Limited
10 2Ayana Pharma
11 6BAXTER HEALTHCARE PTY LTD
12 2Baxter HealthCare South Africa (Pty) Ltd
13 5Baxter Healthcare Corporation
14 1Bayer AG
15 1Bluepharma
16 3Bristol Myers Squibb
17 2Cipla Medpro South Africa
18 1Deva Holding AS
19 1Dr Reddy's Laboratories (Pty) Ltd
20 3EBEWE Pharma Ges.m.b.H Nfg. KG
21 1EBEWE Pharma Ges.mbHNfg.KG
22 2Flagship Biotech International Pvt. Ltd
23 1Fresenius Kabi USA
24 2Fresenius SE & Co. KGaA
25 1GLAND PHARMA LIMITED
26 6GetWell Pharmaceutical
27 1Health Biotech
28 1Healthcare Pharmaceuticals
29 5Hikma Pharmaceuticals
30 1Intelliscend
31 3Janssen-Cilag
32 2Jodas Expoim Pvt. Ltd
33 3Key Oncologics
34 2Lupin Ltd
35 3Naprod Life Sciences
36 2Nishchay Pharmaceuticals Pvt. Ltd.
37 1Norvium
38 4Oethmaan Biosims
39 1Panacea Biotec Limited
40 4Pfizer Consumer Healthcare
41 30Pfizer Inc
42 5Pharmachemie
43 8Pharmachemie (Pty) Ltd
44 1Pharmaplan
45 3SEACROSS PHARMACEUTICALS
46 1Sagent Pharmaceuticals
47 3Sakar Healthcare
48 7Sandoz B2B
49 10Sun Pharmaceutical Industries Limited
50 1Taro Pharmaceutical Industries
51 13Teva Pharmaceutical Industries
52 4TherDose Pharma
53 4Viatris
54 2Vinkem Labs Ltd
55 1Zhejiang Hisun Pharmaceutical
56 2Zydus Lifesciences
57 9Blank
01 4CONCENTRATE FOR SOLUTION FOR INFUSION
02 4Concentrate to the infusion fluid
03 1Concentrate to the infusion fluid, resolution
04 1Concentrated Solution
05 1Concentrated Solution Perfusion
06 1Doxorubicin 100Mg 50Ml 1 Units Parenteral Use
07 6Doxorubicin 10Mg 5Ml 1 Units Parenteral Use
08 3Doxorubicin 200Mg 100Ml 1 Units Parenteral Use
09 1Doxorubicin 20Mg 10Ml 1 Units Parenteral Use
10 1Doxorubicin 50Mg 1 Unit Parenteral Use
11 1Doxorubicin 50Mg 2 Units Parenteral Use
12 4Doxorubicin 50Mg 25Ml 1 Units Parenteral Use
13 2Dry Sub
14 11INF
15 23INJ
16 14INJECTABLE, LIPOSOMAL;INJECTION
17 38INJECTABLE;INJECTION
18 6INJECTION
19 1Inf Conc
20 3Inj L?s
21 1Inj Sol
22 5Inj Solution
23 2Injectable Infusion
24 3Injectable Intravenous Solution
25 1Injectable; Injection
26 22Injection
27 5Injection fluid, resolution
28 1Liposomal Injection
29 1Liposome Injection
30 1Liquid Injection
31 2Lyo.Inj
32 2Lyophilised Injection
33 1POI
34 1POWDER FOR CONCENTRATE FOR
35 2POWDER FOR SOLUTION
36 1PULVER, DISPERSION OCH VÄTSKA TILL
37 1Powder For Oral Solution
38 1Powder and liquids to concentrate for infusion, liposomaldispersjon
39 2Powder for injection fluid, resolution
40 2SOL
41 6SOLUTION
42 2SOLUTION FOR INJECTION
43 2SUSPENSION
44 1Vial
45 1Vial Of Lyophilised
46 18Blank
01 22DISCN
02 45Generic
03 2Lead Market Dossiers- Approved in US and Under review in EU
04 1Lead Market Dossiers- Filed
05 6Originator
06 30RX
07 107Blank
01 11 Farmiblastina 10Mg Vial 1 Blister Powder And Solvent For Solution For Injection
02 11 Farmiblastina 10Mg Vial Solution + 1 Blister
03 11 Farmiblastina 50Mg Vial Of Lyophilised
04 11 Farmiblastina Solution 50Mg Vial 25Ml
05 2ADRIAMYCIN PFS
06 9Adriamycin
07 2Adriblastin RD
08 3Adriblastin Sol
09 5Adriblastina
10 1Adriblastina CSV 10mg/5ml
11 1Adriblastina CSV 50mg/25ml
12 1Adriblastina RD 10mg
13 1Adriblastina RD 50mg
14 1CAELYX
15 12Caelyx
16 1Cipla Doxorubicin 10
17 1Cipla Doxorubicin 50
18 2DOXIL (LIPOSOMAL)
19 1DOXOPEG
20 4DOXORUBA
21 1DOXORUBICIN
22 1DOXORUBICIN -SOL PCH 10MG
23 1DOXORUBICIN 10mg/5ml FRESENIUS
24 1DOXORUBICIN 50mg/25ml FRESENIUS
25 33DOXORUBICIN HYDROCHLORIDE
26 12DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
27 2DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
28 1DOXORUBICIN HYDROCHLORIDE INJECTION
29 1DOXORUBICIN INJECTION, BP
30 1DOXORUBICIN-SOL PCH 50MG
31 2DOXOTHER
32 1Doxolip
33 1Doxonish 10
34 1Doxonish 50
35 10Doxorubicin
36 1Doxorubicin "Ebewe" 10mg (5ml vial)
37 1Doxorubicin "Ebewe" 50mg (25ml vial)
38 1Doxorubicin - Pch 10
39 2Doxorubicin ACC
40 5Doxorubicin Accord
41 1Doxorubicin Accord 10mg/5ml
42 1Doxorubicin Accord 2Mg/Ml 1 Vial 50Mg/25Ml Concentr Solution Perf Efg
43 1Doxorubicin Accord 2Mg/Ml 1 Vial 50Ml Drip Soluc Concentr Efg
44 1Doxorubicin Accord 50mg/25ml
45 1Doxorubicin Actavis
46 1Doxorubicin Aurovitas 2Mg/Ml 25Ml Vial 1 (50Mg/25Ml) Concentrated Sun Perf Efg
47 1Doxorubicin Aurovitas 2Mg/Ml 50Ml Vial 1 (100Mg/50Ml) Grant Sun Perf Efg
48 4Doxorubicin Ebewe
49 2Doxorubicin Mylan
50 1Doxorubicin Pch
51 1Doxorubicin Pch 10 10Mg Vial
52 1Doxorubicin Pch 50
53 1Doxorubicin Rtu
54 1Doxorubicin Rtu 10-5 5Ml
55 1Doxorubicin Rtu 200-100 100Ml
56 1Doxorubicin Rtu 50-25 25Ml
57 4Doxorubicin Sandoz eco
58 1Doxorubicin Tedec 2Mg/Ml 25Ml Vial Soluc 1 Pb
59 1Doxorubicin hcl faulfing powder vial
60 1Doxorubicin-Hexal 10Mg/5Ml
61 1Doxorubicin-Hexal 50Mg/25Ml
62 2Doxorubicin-Teva
63 1Doxred 10 Lyophilized Powder
64 1Doxred 10mg/5ml
65 1Doxred 50 Lyophilized Powder
66 1Doxred 50mg/25ml
67 2I-DOX
68 6Liposomal Doxorubicin SUN
69 3Myocet
70 3RUBEX
71 1Rubexet 10mg/5ml
72 1Rubexet 200mg/100ml
73 1Rubexet 50mg/25ml
74 1Sopilcin 20 mg/10 ml
75 1TARO-DOXORUBICIN LIPOSOMAL
76 1doxorubicin
77 29Blank
01 18Australia
02 7Canada
03 35India
04 17Italy
05 13Norway
06 1Portugal
07 37South Africa
08 9Spain
09 8Sweden
10 12Switzerland
11 1Turkey
12 52USA
13 3United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG/25ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 1995-11-17
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2000-06-13
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1985-05-20
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/VIAL
Packaging :
Approval Date : 1987-07-22
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date : 1987-12-23
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 200MG/100ML
Packaging :
Approval Date : 1988-05-03
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/75ML
Packaging :
Approval Date : 2011-03-28
Application Number : 50629
Regulatory Info : DISCN
Registration Country : USA
